A nurse is completing an incident report after a client fall. Which of the following competencies of Quality and Safety Education for Nurses is the nurse demonstrating?

Choice A reason: Persistent headache on oral contraceptives may indicate serious complications like stroke or hypertension, requiring immediate reporting to prevent life-threatening events. This is critical for timely intervention, ensuring client safety, and guiding potential medication adjustments in women using hormonal contraception for 6 months.

Choice B reason: Weight gain of 2.3 kg is common with oral contraceptives and not urgent, unlike persistent headache, which signals serious risks. Assuming weight gain requires reporting risks overlooking critical neurological symptoms, critical to avoid in ensuring safe monitoring of contraceptive side effects.

Choice C reason: Frequent nausea is a common contraceptive side effect, typically managed with counseling, not urgent like headache. Assuming nausea is priority risks delaying serious symptom evaluation, critical to prevent in ensuring timely reporting of potentially life-threatening complications in contraceptive users.

Choice D reason: Breast tenderness is a common, non-urgent side effect of oral contraceptives, unlike persistent headache, which may indicate stroke risk. Assuming tenderness is urgent risks missing critical symptoms, critical to avoid in ensuring proper monitoring and safety in clients on hormonal contraception.

Choice A reason: Increased blood pressure is not an effect of furosemide, which reduces fluid volume, lowering pressure. Weight loss indicates efficacy. Assuming increased pressure is correct risks misinterpreting diuresis, potentially delaying further fluid management, critical to avoid in treating fluid volume excess effectively.

Choice B reason: Decreased pain is unrelated to furosemide’s diuretic action, which targets fluid reduction, evidenced by weight loss. Assuming pain reduction is an indicator risks missing fluid status changes, critical to prevent in ensuring accurate assessment of furosemide’s effectiveness in fluid volume excess treatment.

Choice C reason: Decreased inflammation is not a furosemide effect; it promotes diuresis, reducing fluid, shown by weight loss. Assuming inflammation reduction is relevant risks misjudging medication efficacy, potentially overlooking fluid overload signs, critical to avoid in managing fluid volume excess with diuretic therapy.

Choice D reason: Weight loss indicates furosemide’s effectiveness, as it reduces fluid volume excess through diuresis, decreasing edema and body weight. This is critical for assessing therapeutic response, ensuring fluid balance, preventing complications like heart failure, and guiding further treatment in clients with fluid overload.